Xu J - Search Results

1

PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.

Jiang H, Zhu Y, Zhou Z, Xu J, Jin S, Xu K, Zhang H, Sun Q, Wang J, Xu J. Jiang H, et al. Among authors: xu k, xu j. Cancer Med. 2018 Mar;7(3):869-882. doi: 10.1002/cam4.1360. Epub 2018 Feb 14. Cancer Med. 2018. PMID: 29441724 Free PMC article.

2

PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.

Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, Sun Q, Wang J, Xu J. Jiang H, et al. Among authors: xu k, xu j. Cancer Sci. 2018 May;109(5):1414-1427. doi: 10.1111/cas.13598. Cancer Sci. 2018. PMID: 29603830 Free PMC article.

3

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma.

Jin S, Wang K, Xu K, Xu J, Sun J, Chu Z, Lin D, Koeffler PH, Wang J, Yin D. Jin S, et al. Among authors: xu k, xu j. Oncotarget. 2014 Jun 15;5(11):3685-96. doi: 10.18632/oncotarget.1986. Oncotarget. 2014. PMID: 25003523 Free PMC article.

4

High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.

He C, Xu J, Zhang J, Xie D, Ye H, Xiao Z, Cai M, Xu K, Zeng Y, Li H, Wang J. He C, et al. Among authors: xu k, xu j. Hum Pathol. 2012 Sep;43(9):1425-35. doi: 10.1016/j.humpath.2011.11.003. Epub 2012 Mar 9. Hum Pathol. 2012. PMID: 22406368

5

Therapeutic significance and indications of pulmonary metastasectomy for hepatocellular carcinoma following liver resection.

Hu Z, Li W, Huang P, Zhou Z, Xu J, Xu K, Wang J, Zhang H. Hu Z, et al. Among authors: xu k, xu j. Int J Surg. 2017 Dec;48:23-31. doi: 10.1016/j.ijsu.2017.09.075. Epub 2017 Oct 5. Int J Surg. 2017. PMID: 28987561 Free article.

6

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Zhang H, Zheng Z, Zhang R, Yan Y, Peng Y, Ye H, Lin L, Xu J, Li W, Huang P. Zhang H, et al. Among authors: xu j. Cell Death Dis. 2021 Jul 23;12(8):731. doi: 10.1038/s41419-021-04009-8. Cell Death Dis. 2021. PMID: 34301921 Free PMC article.

7

Isolated brain metastases prior to locoregional recurrence in hilar cholangiocarcinoma.

Yu Z, Xu J, Wang J. Yu Z, et al. Among authors: xu j. Mol Clin Oncol. 2017 Jun;6(6):899-902. doi: 10.3892/mco.2017.1253. Epub 2017 May 8. Mol Clin Oncol. 2017. PMID: 28588786 Free PMC article.

8

Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma.

Yu Z, Zhu J, Jiang H, He C, Xiao Z, Wang J, Xu J. Yu Z, et al. Among authors: xu j. Indian J Surg. 2018 Aug;80(4):309-317. doi: 10.1007/s12262-016-1581-z. Epub 2017 Jan 7. Indian J Surg. 2018. PMID: 32288384 Free PMC article.

9

PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.

Zhang Y, Zhang J, Xu K, Xiao Z, Sun J, Xu J, Wang J, Tang Q. Zhang Y, et al. Among authors: xu k, xu j. Hepatogastroenterology. 2013 Oct;60(127):1766-72. Hepatogastroenterology. 2013. PMID: 24624456

10

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Zhang H, Zheng Z, Zhang R, Yan Y, Peng Y, Ye H, Lin L, Xu J, Li W, Huang P. Zhang H, et al. Among authors: xu j. Cell Death Dis. 2021 Aug 16;12(9):793. doi: 10.1038/s41419-021-04071-2. Cell Death Dis. 2021. PMID: 34400616 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,194 results

Search Page

Filters